The Role of UCMSC Derived Secretome in Collagen Remodeling During Skin Photoaging Molecular Mechanisms and Therapeutic Potential

Fanni Yuniar, Endang Purwaningsih, Nunung Ainur Rahmah, Nenden Lilis

Abstract

Introduction: Skin photoaging is characterized by progressive disruption of the dermal extracellular matrix, particularly an imbalance between collagen synthesis and degradation. Umbilical cord mesenchymal stem cell-derived secretome has emerged as a promising cell-free regenerative approach because it contains soluble factors and extracellular vesicles capable of influencing skin repair and collagen homeostasis.

Methods: A structured literature search was conducted in PubMed, Scopus, and ScienceDirect for studies published from January 2016 to June 2026. Studies evaluating conditioned medium, whole secretome, extracellular vesicles, or exosomes derived from umbilical cord or Wharton’s jelly mesenchymal stem cells in skin aging, photoaging, ultraviolet-induced skin damage, or collagen remodeling were included. The study-selection process followed the PRISMA 2020 framework. Of 166 identified records, 14 studies were included in the narrative synthesis.

Results: Most evidence was derived from in vitro, ex vivo, and animal studies, while human evidence was limited to small, short-term investigations. UCMSC-derived products were associated with increased collagen expression, procollagen production, collagen deposition, and improved dermal organization. They also reduced collagen-degrading matrix metalloproteinases and supported fibroblast survival. The proposed mechanisms involved antioxidant, anti-inflammatory, antisenescence, and extracellular-matrix-regulatory pathways. Comparative findings suggested that UCMSC-derived secretome may have particular antioxidant and antisenescence advantages, although it was not consistently superior to secretomes from other MSC sources

Conclusion: UCMSC-derived secretome shows potential for supporting collagen remodeling in photoaged skin. However, methodological heterogeneity, inconsistent product characterization, and limited controlled clinical evidence prevent definitive conclusions. Standardized manufacturing and well-designed clinical trials are required to establish its efficacy, safety, and clinical applicability

Keywords

collagen; remodeling; secretome; photoaging; skin; UCMSC

Full Text:

PDF

References

  1. Pittayapruek P, Meephansan J, Prapapan O, et al. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis. Int J Mol Sci 2016;17(6); doi: 10.3390/IJMS17060868.
  2. Shin JW, Kwon SH, Choi JY, et al. Molecular Mechanisms of Dermal Aging and Antiaging Approaches. Int J Mol Sci 2019;20(9):2126; doi: 10.3390/IJMS20092126.
  3. Lee LY, Liu SX. Pathogenesis of Photoaging in Human Dermal Fibroblasts. Int J Dermatol Venereol 2022;3(1):37–42; doi: 10.1097/JD9.0000000000000068.
  4. Ferreira JR, Teixeira GQ, Santos SG, et al. Mesenchymal stromal cell secretome: Influencing therapeutic potential by cellular pre-conditioning. Front Immunol 2018;9:425936; doi: 10.3389/fimmu.2018.02837.
  5. Harrell CR, Fellabaum C, Jovicic N, et al. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells 2019, Vol 8, Page 467 2019;8(5):467; doi: 10.3390/CELLS8050467.
  6. Vizoso FJ, Eiro N, Cid S, et al. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. Int J Mol Sci 2017;18(9):1852; doi: 10.3390/IJMS18091852.
  7. Ahangar P, Mills SJ, Cowin AJ. Mesenchymal Stem Cell Secretome as an Emerging Cell-Free Alternative for Improving Wound Repair. International Journal of Molecular Sciences 2020, Vol 21, Page 7038 2020;21(19):7038; doi: 10.3390/IJMS21197038.
  8. Ahn H, Lee KH, Han HS. Efficacy and safety of umbilical cord-derived mesenchymal stem cell-conditioned media for preventing and treating skin aging. World J Stem Cells 2025;17(9):108049; doi: 10.4252/WJSC.V17.I9.108049.
  9. Lee NE, Hwang JI, Bang CY, et al. Wharton’s jelly mesenchymal stem cell-secretome enhances skin rejuvenation via ApoA4 and SERPINH1. Regen Ther 2026;31; doi: 10.1016/J.RETH.2026.101071.
  10. Lee NE, Kim JE, Bang CY, et al. Nano-Encapsulated Spicule System Enhances Delivery of Wharton’s Jelly MSC Secretome and Promotes Skin Rejuvenation: Preclinical and Clinical Evaluation. Int J Mol Sci 2025;26(20); doi: 10.3390/IJMS262010024.
  11. Ponnikorn S, Thanasarnaksorn W, Hongeng S, et al. Biologically Distinct, Clinically Convergent: A Comparative Study of Umbilical Cord- and Adipose-Derived Mesenchymal Stem Cell Exosomes in Human Skin Regeneration. Aesthet Surg J 2026;46:S38–S53; doi: 10.1093/ASJ/SJAF254.
  12. Zhang H, Xiao X, Wang L, et al. Human adipose and umbilical cord mesenchymal stem cell-derived extracellular vesicles mitigate photoaging via TIMP1/Notch1. Signal Transduct Target Ther 2024;9(1); doi: 10.1038/S41392-024-01993-Z.
  13. Widowati W, Faried A, Adam A, et al. Potential antiaging activity of secretome gel of human Wharton’s jelly mesenchymal stem cells (hWJ-MSCs) in UV-induced mice models. Iran J Basic Med Sci 2024;27(7):868–878; doi: 10.22038/IJBMS.2024.70825.15385.
  14. Gowen A, Shahjin F, Chand S, et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications. Front Cell Dev Biol 2020;8:518114; doi: 10.3389/FCELL.2020.00149/FULL.
  15. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018;7(1); doi: 10.1080/20013078.2018.1535750.
  16. Welsh JA, Goberdhan DCI, O’Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles 2024;13(2):e12404; doi: 10.1002/JEV2.12404;PAGEGROUP:STRING:PUBLICATION.
  17. Vu DM, Nguyen VT, Nguyen TH, et al. Effects of Extracellular Vesicles Secreted by TGFβ-Stimulated Umbilical Cord Mesenchymal Stem Cells on Skin Fibroblasts by Promoting Fibroblast Migration and ECM Protein Production. Biomedicines 2022;10(8); doi: 10.3390/BIOMEDICINES10081810.
  18. 18. Quintero-Gil C, Jaraba-Alvarez W, Franco-Salazar JP, et al. Cryopreserved exosomes derived from hypoxic Wharton’s jelly mesenchymal stromal cells enhance fibroblast proliferation, upregulate COL1A2 expression, and mitigate senescence. Front Med (Lausanne) 2025;12:1692585; doi: 10.3389/FMED.2025.1692585/TEXT.
  19. Wu P, Zhang B, Han X, et al. HucMSC Exosome-Delivered 14-3-3ζ Alleviates Ultraviolet Radiation-Induced Photodamage via SIRT1 Pathway Modulation. 2021;13(8), 11542.
  20. Gui Q, Ding N, Liu J, et al. miR-200a-3p in Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Attenuates UVB-Induced Skin Inflammatory Response and Oxidative Stress via Keap1-Nrf2 Pathway. Stem Cells Int 2025;2025(1); doi: 10.1155/SCI/7831890.
  21. Sandra F, Dewi DAR, Astawa INM, et al. Inhibition of Ultraviolet B-induced Apoptosis in Fibroblasts by Human Umbilical Cord Blood Mesenchymal Stem Cell Conditioned Media via the Phosphatidylinositol-3-Kinase/Akt Pathway. Iran J Med Sci 2025;50(1):44–53; doi: 10.30476/IJMS.2024.100856.3342.
  22. He C, Wang Z, Jiang Z, et al. Microneedles combining delivery of hUMSC-derived exosomes and EGCG mitigate UV-induced skin damage. Journal of Nanobiotechnology 2025 23:1 2025;23(1):643-; doi: 10.1186/S12951-025-03735-X.
  23. U.S. Food and Drug Administration. Public Safety Notification on Exosome Products. 2019. Available from: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products [Last accessed: 6/30/2026].

DOI: https://doi.org/10.13057/smj.v9i2.123080

Refbacks

  • There are currently no refbacks.